The Assessment of Muscle Strength and Cardiorespiratory Parameters Using Simple Tests in Older Adults With Recovery From Mild COVID-19
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: To evaluate muscle strength and cardiorespiratory parameters, this study uses simple tests in older adults, including those who have and have not recovered from mild coronavirus disease 2019 (COVID-19).Methods: Eighty older adults (age≥60 years old) were divided into two groups: those without previous COVID-19 (control group, n=40) and those with recovery from mild COVID-19 (recovered group, n=40). Muscle strength was assessed using a handgrip strength test and the sit-to-stand test (STS10). Cardiorespiratory parameters were evaluated with a 1-minute sitto- stand (1-min STS) test and a 6-minute walk test (6MWT).Results: Both groups had normal values for body mass index, blood pressure, heart rate, and pulse oxygen saturation. The recovered group showed significant differences in handgrip strength test (24.73±6.99 vs. 22.03±4.36, p=0.041) and duration for the STS10 (25.15±6.11 vs. 33.40±7.56, p<0.001) when compared to the control group. Furthermore, the recovered group had significantly decreased repetitions of a 1-min STS (31.38±4.89 vs. 21.25±3.64, p<0.001) and increased the rate of perceived exertion (RPE) (7.43±1.20 vs. 8.95±1.01, p=0.01) and leg fatigue (1.49±1.13 vs. 3.00±1.04, p=0.03) after performing a 1-min STS when compared with the control group. Moreover, the recovered group had also significantly decreased distances for the 6MWT (421.68±8.28 vs. 384.35±6.17, p<0.001) and increased the post-test RPE (7.63±1.37 vs. 12.05±1.63, p<0.001) and the post-test leg fatigue (1.71±0.88 vs. 5.28±0.91, p<0.001) compared with the control group.Conclusion: Older adults with recovery from mild COVID-19 reported reduced muscle strength and exercise tolerance when compared with older adults without COVID-19.
Abstract
Objective: To evaluate muscle strength and cardiorespiratory parameters, this study uses simple tests in older adults, including those who have and have not recovered from mild coronavirus disease 2019 (COVID-19).Methods: Eighty older adults (age≥60 years old) were divided into two groups: those without previous COVID-19 (control group, n=40) and those with recovery from mild COVID-19 (recovered group, n=40). Muscle strength was assessed using a handgrip strength test and the sit-to-stand test (STS10). Cardiorespiratory parameters were evaluated with a 1-minute sitto- stand (1-min STS) test and a 6-minute walk test (6MWT).Results: Both groups had normal values for body mass index, blood pressure, heart rate, and pulse oxygen saturation. The recovered group showed significant differences in handgrip strength test (24.73±6.99 vs. 22.03±4.36, p=0.041) and duration for the STS10 (25.15±6.11 vs. 33.40±7.56, p<0.001) when compared to the control group. Furthermore, the recovered group had significantly decreased repetitions of a 1-min STS (31.38±4.89 vs. 21.25±3.64, p<0.001) and increased the rate of perceived exertion (RPE) (7.43±1.20 vs. 8.95±1.01, p=0.01) and leg fatigue (1.49±1.13 vs. 3.00±1.04, p=0.03) after performing a 1-min STS when compared with the control group. Moreover, the recovered group had also significantly decreased distances for the 6MWT (421.68±8.28 vs. 384.35±6.17, p<0.001) and increased the post-test RPE (7.63±1.37 vs. 12.05±1.63, p<0.001) and the post-test leg fatigue (1.71±0.88 vs. 5.28±0.91, p<0.001) compared with the control group.Conclusion: Older adults with recovery from mild COVID-19 reported reduced muscle strength and exercise tolerance when compared with older adults without COVID-19.
참고문헌 (40)
- Ozma MA, "Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2(COVID-19)during the outbreak period", Infez Med, 28, pp.153~165 (2020)
- Li LQ, "COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis", J Med Virol, 92, pp.577~583 (2020)
- Jacobs LG, "Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection", PLoS One, 15, pp.e0243882~ (2020)
- Sagarra-Romero L, "COVID-19 : short and long-term effects of hospitalization on muscular weakness in the elderly", Int J Environ Res Public Health, 17, pp.8715~ (2020)
- Van Aerde N, "Intensive care unit acquired muscle weakness in COVID-19 patients", Intensive Care Med, 46, pp.2083~2085 (2020)
- Ferrandi PJ, "The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies", J Appl Physiol(1985), 129, pp.864~867 (2020)
- Dos Santos PK, "The musculoskeletal involvement after mild to moderate COVID-19 infection", Front Physiol, 13, pp.813924~ (2022)
- Leung TW, "Myopathic changes associated with severe acute respiratory syndrome : a postmortem case series", Arch Neurol, 62, pp.1113~1117 (2005)
- Aiyegbusi OL, "Symptoms, complications and management of long COVID: a review", J R Soc Med, 114, pp.428~442 (2021)
- Stavem K, "Persistent symptoms 1. 5-6 months after COVID-19 in non-hospitalised subjects : a population-based cohort study", Thorax, 76, pp.405~407 (2021)
- Vanichkachorn G, "Post-COVID-19 Syndrome(Long Haul Syndrome) : description of a multidisciplinary clinic at mayo clinic and characteristics of the initial patient cohort", Mayo Clin Proc, 96, pp.1782~1791 (2021)
- Stavem K, "Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects : a population-based study", Int J Environ Res Public Health, 18, pp.2030~ (2021)
- Amenta EM, "Postacute COVID-19 : an overview and approach to classification", Open Forum Infect Dis, 7, pp.ofaa509~ (2020)
- Rudroff T, "Post-COVID-19 fatigue : potential contributing factors", Brain Sci, 10, pp.1012~ (2020)
- Miyazato Y, "Prolonged and late-onset symptoms of Coronavirus Disease 2019", Open Forum Infect Dis, 7, pp.ofaa507~ (2020)
- Sudre CH, "Attributes and predictors of long COVID", Nat Med, 27, pp.626~631 (2021)
- Yelin D, "Long COVID-19-it’s not over until?", Clin Microbiol Infect, 27, pp.506~508 (2021)
- Romero Starke K, "The isolated effect of age on the risk of COVID-19 severe outcomes : a systematic review with meta-analysis", BMJ Glob Health, 6, pp.e006434~ (2021)
- Zhang H, "Age-related risk factors and complications of patients with COVID-19 : a population-based retrospective study", Front Med(Lausanne), 8, pp.757459~ (2022)
- Paneroni M, "Muscle strength and physical performance in patients without previous disabilities recovering from COVID-19 pneumonia", Am J Phys Med Rehabil, 100, pp.105~109 (2021)
- Welch C, "COVID-19 and acute sarcopenia", Aging Dis, 11, pp.1345~1351 (2020)
- Tanriverdi A, "Extrapulmonary features of post-COVID-19 patients : muscle function, physical activity, mood, and sleep quality", Ir J Med Sci, 191, pp.969~975 (2022)
- Barbosa MH, "Body mass index as discriminator of the lean mass deficit and excess body fat in institutionalized elderly people", Geriatr Nurs, 36, pp.202~206 (2015)
- Segura-Ortí E, "Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis", Phys Ther, 91, pp.1244~1252 (2011)
- ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, "ATS statement : guidelines for the six-minute walk test", Am J Respir Crit Care Med, 166, pp.111~117 (2002)
- Balachandran AT, "Validity, reliability, and measurement error of a sit-to-stand power test in older adults : a pre-registered study", Exp Gerontol, 145, pp.111202~ (2021)
- Disser NP, "Musculoskeletal consequences of COVID-19", J Bone Joint Surg Am, 102, pp.1197~1204 (2020)
- Hoffmann M, "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271~280 (2020)
- Benton DJ, "Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion", Nature, 588, pp.327~330 (2020)
- Montes-Ibarra M, "The impact of long COVID-19 on muscle health", Clin Geriatr Med, 38, pp.545~557 (2022)
- Mittal J, "High prevalence of post COVID-19 fatigue in patients with type 2 diabetes : a case-control study", Diabetes Metab Syndr, 15, pp.102302~ (2021)
- Akbarialiabad H, "Long COVID, a comprehensive systematic scoping review", Infection, 49, pp.1163~1186 (2021)
- Docherty AB, "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study", BMJ, 369, pp.m1985~ (2020)
- Ong KC, "Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome", Eur Respir J, 24, pp.436~442 (2004)
- Reeves WC, "Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution", BMC Health Serv Res, 3, pp.25~ (2003)
- Jennings G, "A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19 : ongoing symptomatic phase vs. post-COVID-19 syndrome", J Clin Med, 10, pp.5913~ (2021)
- Jahn K, "Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning", Eur Respir J, 59, pp.2101136~ (2021)
- Ferreira EVM, "Mechanisms of exercise intolerance after COVID-19 : new perspectives beyond physical deconditioning", J Bras Pneumol, 47, pp.e20210406~ (2021)
- Fagard RH, "Effect of exercise on blood pressure control in hypertensive patients", Eur J Cardiovasc Prev Rehabil, 14, pp.12~17 (2007)
- Lavie CJ, "Exercise and the cardiovascular system : clinical science and cardiovascular outcomes", Circ Res, 117, pp.207~219 (2015)